Danielle Enserro
AuthID: R-00K-25M
1
TITLE: Reply to F. Tomao et al
AUTHORS: Martee L Hensley; Danielle Enserro; David Scott Miller ;
PUBLISHED: 2019, SOURCE: Journal of Clinical Oncology, VOLUME: 37, ISSUE: 11
AUTHORS: Martee L Hensley; Danielle Enserro; David Scott Miller ;
PUBLISHED: 2019, SOURCE: Journal of Clinical Oncology, VOLUME: 37, ISSUE: 11
INDEXED IN: 
Scopus 
CrossRef
Scopus CrossRef2
TITLE: The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study Full Text
AUTHORS: Nick M Spirtos; Danielle Enserro; Howard D Homesley; Susan K Gibbons; David Cella; Robert T Morris; Koen DeGeest; Roger B Lee; David Scott Miller ;
PUBLISHED: 2019, SOURCE: Gynecologic Oncology, VOLUME: 154, ISSUE: 1
AUTHORS: Nick M Spirtos; Danielle Enserro; Howard D Homesley; Susan K Gibbons; David Cella; Robert T Morris; Koen DeGeest; Roger B Lee; David Scott Miller ;
PUBLISHED: 2019, SOURCE: Gynecologic Oncology, VOLUME: 154, ISSUE: 1
3
TITLE: Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: A phase III NRG oncology/gynecologic oncology group study
AUTHORS: Martee L Hensley; Danielle Enserro; Helen Hatcher; Petronella B Ottevanger; Anders Krarup Hansen; Jean Yves Blay; Cyril Fisher; Katherine M Moxley; Shashikant B Lele; Jayanthi S Lea; Krishnansu S Tewari; Premal H Thaker; Oliver Zivanovic; David M O'Malley; Katina Robison; David Scott Miller ;
PUBLISHED: 2018, SOURCE: Journal of Clinical Oncology, VOLUME: 36, ISSUE: 33
AUTHORS: Martee L Hensley; Danielle Enserro; Helen Hatcher; Petronella B Ottevanger; Anders Krarup Hansen; Jean Yves Blay; Cyril Fisher; Katherine M Moxley; Shashikant B Lele; Jayanthi S Lea; Krishnansu S Tewari; Premal H Thaker; Oliver Zivanovic; David M O'Malley; Katina Robison; David Scott Miller ;
PUBLISHED: 2018, SOURCE: Journal of Clinical Oncology, VOLUME: 36, ISSUE: 33
